These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1848440)

  • 1. Inositol metabolism in mononuclear leucocytes from patients with atopic dermatitis.
    Coulson IH; Hurt GR; Holden CA
    Br J Dermatol; 1991 Feb; 124(2):124-9. PubMed ID: 1848440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis.
    Sawai T; Ikai K; Uehara M
    Br J Dermatol; 1995 Jan; 132(1):22-4. PubMed ID: 7756148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered phosphorylation as a possible basis for cyclic nucleotide abnormalities in atopic dermatitis.
    Hanifin JM; Chan SC; Hirschman CA
    Acta Derm Venereol Suppl (Stockh); 1985; 120():47-9. PubMed ID: 3010615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopic dermatitis: a defect of intracellular secondary messenger systems?
    Holden CA
    Clin Exp Allergy; 1990 Mar; 20(2):131-6. PubMed ID: 2162724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-interferon production in atopic dermatitis shows differential modification by phosphodiesterase and prostaglandin inhibition.
    Ostlere LS; Mallett RB; Kaminski A; Kaminski ER; Pereira RS; Holden CA
    Br J Dermatol; 1995 Jul; 133(1):1-5. PubMed ID: 7669618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of mononuclear leukocyte cyclic adenosine monophosphate-phosphodiesterase activity to treatment with topical fluorinated steroid ointment in atopic dermatitis.
    Holden CA; Yuen CT
    J Am Acad Dermatol; 1989 Jul; 21(1):69-74. PubMed ID: 2545750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of in vitro exposure to histamine on mononuclear leucocyte phosphodiesterase activity in atopic dermatitis.
    Holden CA; Yuen CT; Coulson IH
    Clin Exp Dermatol; 1989 May; 14(3):186-90. PubMed ID: 2556225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Butler JM; Ebertz M; Chan SC; Stevens SR; Sobieszczuk D; Hanifin JM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():55-60. PubMed ID: 2408432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy.
    Sawai T; Ikai K; Uehara M
    Br J Dermatol; 1998 May; 138(5):846-8. PubMed ID: 9666832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis.
    Chan SC; Kim JW; Henderson WR; Hanifin JM
    J Immunol; 1993 Sep; 151(6):3345-52. PubMed ID: 8397256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
    Butler JM; Chan SC; Stevens S; Hanifin JM
    J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis.
    Coulson IH; Duncan SN; Holden CA
    Br J Dermatol; 1989 May; 120(5):607-12. PubMed ID: 2547417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic adenosine monophosphate-phosphodiesterase activity in cultured keratinocytes from patients with atopic eczema.
    Wright S; Navsaria H; Leigh IM
    J Dermatol Sci; 1991 Jul; 2(4):263-7. PubMed ID: 1655006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of phosphoinositide-specific phospholipase C activity in mononuclear leucocytes from atopic and normal subjects.
    Mallett RB; Myint S; Holden CA
    Br J Dermatol; 1992 Aug; 127(2):97-102. PubMed ID: 1390161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis.
    Schopf RE; Weber H; Morsches B
    Arch Dermatol Res; 1993; 285(5):305-9. PubMed ID: 8379692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased leukocyte sensitivity to phosphodiesterase inhibitors in atopic dermatitis: tachyphylaxis after theophylline therapy.
    Giustina TA; Chan SC; Thiel ML; Baker JW; Hanifin JM
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 1):252-7. PubMed ID: 6088608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiochemical aspects of atopic dermatitis.
    Hanifin JM
    Acta Derm Venereol Suppl (Stockh); 1989; 144():45-7. PubMed ID: 2552722
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracellular 3',5'-adenosine cyclic monophosphate level regulates house dust mite-induced interleukin-13 production by T cells from mite-sensitive patients with atopic dermatitis.
    Kanda N; Watanabe S
    J Invest Dermatol; 2001 Jan; 116(1):3-11. PubMed ID: 11168792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis.
    Banner KH; Roberts NM; Page CP
    Br J Pharmacol; 1995 Dec; 116(8):3169-74. PubMed ID: 8719792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parents.
    Heskel NS; Chan SC; Thiel ML; Stevens SR; Casperson LS; Hanifin JM
    J Am Acad Dermatol; 1984 Sep; 11(3):422-6. PubMed ID: 6090514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.